Potential Effects of Melatonin on TRPA1 Channels in the Prevention and Treatment of Alzheimer's Disease
Authors:
- 17 August 2022
- journal article
- research article
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 59 (3) , 188-192
Abstract
Introduction: Alzheimer's disease (AD) is the most common cause of dementia and is defined as a progressive neurodegenerative disease. Main clinical features of AD are progressive impairment in learning and memory loss. Several studies have indicated that mitochondria play a critical role in the pathogenesis of AD. In this study, we investigated the effect of melatonin on mitochondria-dependent TRPA1 ion channels in neuroblastoma cells by creating an in vitro model of Alzheimer's disease. Methods: Okadaic acid was applied to SH-SY5Y (human neuroblastoma cell line) cells to create an AD model. After cellular differentiation, the following 7 main groups were created: Group 1 (Control), Group 2 (Mel+AD), Group 3 (Mel+AD+AP18), Group 4 (AD), Group 5 (AD+AP18), Group 6 (AD+Mel), and Group 7 (AD+Mel+AP18), and Alzheimer's disease was determined in vitro by examining the effect of melatonin on calcium-dependent TRPA1 channels in neuroblastoma cells. Results: The Ca2+ concentration was greater in the melatonin+AD, AD and AD+melatonin groups than in the control (p<0.001). However, there was no statistically significant difference between Mel+AD+AP18, AD+Mel+AP18 and the control. We determined that Ca2+ levels were lower in the melatonin+AD and AD+melatonin groups than in the AD group (p<0.001 and p<0.05). Additionally, cytosolic Ca2+ concentrations were found to be lower in the melatonin+AD group than in the AD+melatonin group (p<0.05). In evaluating the apoptosis and oxidative stress levels, we found that the apoptosis and intracellular ROS values were higher in the melatonin+AD, AD and AD+melatonin groups than in the control (p<0.001). In this respect, the mitochondrial depolarization and caspase-3 and caspase-9 levels were higher in the melatonin+AD, AD and AD+melatonin groups than in the control group (p<0.001). Additionally, the mitochondrial depolarization, caspase-3 and caspase-9 values were higher in the AD group than in the melatonin+AD and AD+melatonin groups (p<0.001), while mitochondrial depolarization and caspase-3 levels were lower in the melatonin+AD group than in the AD+melatonin group (p<0.001). However, in the same groups, there was no statistically significant difference in caspase-9 results. Additionally, the caspase-9 values were lower in the melatonin+AD group, AD group and AD+melatonin groups than in the melatonin+AD+AP18, AD+AP18 and AD+melatonin+AP18 groups, respectively (p<0.001 and p<0.05). Conclusion: Our results suggest that melatonin may be an effective option in the treatment and prophylaxis of Alzheimer's disease by reducing cytosolic Ca2+ concentration, apoptosis and intracellular ROS through TRPA1 channels.Keywords
This publication has 18 references indexed in Scilit:
- Caveolin-1 Regulates the P2Y2 Receptor Signaling in Human 1321N1 Astrocytoma CellsJournal of Biological Chemistry, 2016
- Role of transient receptor potential ankyrin 1 channels in Alzheimer’s diseaseJournal of Neuroinflammation, 2016
- Synergic Effects of Doxorubicin and Melatonin on Apoptosis and Mitochondrial Oxidative Stress in MCF-7 Breast Cancer Cells: Involvement of TRPV1 ChannelsThe Journal of Membrane Biology, 2015
- Sleep and Alzheimer's diseaseSleep Medicine Reviews, 2015
- ITH12410/SC058: A New Neuroprotective Compound with Potential in the Treatment of Alzheimer’s DiseaseACS Chemical Neuroscience, 2014
- Clinical Aspects of Melatonin Intervention in Alzheimers Disease ProgressionCurrent Neuropharmacology, 2010
- Distinct modulation of voltage‐gated and ligand‐gated Ca2+ currents by PPAR‐γ agonists in cultured hippocampal neuronsJournal of Neurochemistry, 2009
- Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's diseaseJournal of Pineal Research, 2004
- Nϵ-Carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's diseaseFree Radical Biology and Medicine, 2004
- Actions of melatonin in the reduction of oxidative stressJournal of Biomedical Science, 2000